The vagus nerve plays a direct role in blood pressure regulation, and reduced vagal tone is consistently associated with hypertension. The relationship is bidirectional — low vagal tone contributes to high blood pressure through several mechanisms, and chronic hypertension itself damages vagal function over time, creating a cycle of worsening autonomic dysfunction. Understanding this connection opens the door to vagal approaches that may complement conventional blood pressure management.
How the Vagus Nerve Regulates Blood Pressure
The vagus nerve participates in blood pressure regulation through three primary mechanisms.
The baroreflex. Baroreceptors in the carotid sinus and aortic arch detect changes in arterial pressure and send afferent signals through the glossopharyngeal nerve (carotid) and vagus nerve (aortic) to the nucleus tractus solitarius (NTS) in the brainstem. When blood pressure rises, these afferents increase their firing rate, which triggers a reflexive increase in vagal output to the heart (producing bradycardia) and a decrease in sympathetic output to blood vessels (producing vasodilation). This baroreflex loop is the body’s primary moment-to-moment blood pressure regulation system, and the vagus nerve is its efferent parasympathetic arm.
Impaired baroreflex sensitivity — where the reflex is sluggish or weakened — is a hallmark of hypertension. The baroreceptors themselves reset to higher operating pressures in chronic hypertension, and the vagal efferent response to baroreflex activation is reduced. This creates a situation where the body’s natural blood pressure correction mechanism is less effective precisely when it is needed most.
Anti-inflammatory pathway. Chronic low-grade inflammation contributes to hypertension through endothelial dysfunction, arterial stiffness, and renal inflammation. The vagus nerve’s cholinergic anti-inflammatory pathway (CAP) suppresses systemic inflammation. Reduced vagal tone means reduced anti-inflammatory braking, which allows inflammation to contribute to vascular damage and blood pressure elevation.
Renal vagal innervation. The vagus nerve innervates the kidneys and modulates renal blood flow, renin secretion, and sodium handling. Vagal renal afferents also provide feedback about renal perfusion pressure to the brainstem. Disruption of this vagal-renal axis may contribute to the sodium retention and renin-angiotensin system activation that drive hypertension.
Evidence Linking Vagal Tone and Blood Pressure
The association between reduced vagal tone (measured by HRV) and hypertension is one of the most consistent findings in autonomic cardiovascular research. Cross-sectional studies consistently show that people with hypertension have lower HRV — particularly the high-frequency (HF) component that specifically reflects vagal cardiac modulation — compared to normotensive controls. Prospective studies show that low HRV predicts the development of hypertension in initially normotensive individuals, suggesting that reduced vagal tone is a precursor to (not just a consequence of) high blood pressure.
The Framingham Heart Study showed that reduced HRV was associated with increased risk of developing hypertension over a follow-up period, independent of baseline blood pressure, age, and other risk factors. A 2014 meta-analysis confirmed the association between reduced HRV and hypertension across multiple populations.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- HRV biofeedback
- Polyvagal-informed therapy
- Somatic therapy
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Vagal Approaches to Blood Pressure
Slow breathing. Device-guided slow breathing (RESPeRATE) is the most evidence-based vagal intervention for blood pressure. Multiple randomised controlled trials and a meta-analysis have shown that daily device-guided breathing at approximately 6 breaths per minute for 15 minutes reduces systolic blood pressure by approximately 3-9 mmHg and diastolic by 2-5 mmHg. This is modest compared to pharmacological treatment but clinically meaningful — a sustained 5 mmHg reduction in systolic blood pressure reduces stroke risk by approximately 14 percent. The American Heart Association has acknowledged slow breathing as a potential adjunctive approach for blood pressure management.
The mechanism is primarily vagal: slow breathing maximises respiratory sinus arrhythmia and increases vagal cardiac output. Over weeks of daily practice, this produces sustained increases in baroreflex sensitivity and vagal tone that extend beyond the practice sessions.
HRV biofeedback. HRV biofeedback — breathing at one’s resonance frequency (typically 5-7 breaths per minute) while watching real-time HRV on a screen — has shown blood pressure reduction in several small trials. A 2019 meta-analysis reported modest but significant reductions in both systolic and diastolic blood pressure with HRV biofeedback training.
Aerobic exercise. Regular aerobic exercise is one of the most effective non-pharmacological blood pressure interventions (reducing systolic BP by approximately 5-8 mmHg) and simultaneously improves vagal tone. The blood pressure and vagal tone effects of exercise likely reinforce each other — improved vagal tone enhances baroreflex sensitivity, which contributes to better blood pressure regulation.
VNS for hypertension. Direct vagus nerve stimulation for treatment-resistant hypertension has been explored in early-phase clinical studies. The rationale is that electrically activating the vagal baroreflex afferent pathway could produce sustained blood pressure reduction. Results have been mixed, and this remains an experimental approach. Baroreceptor activation therapy (stimulating the carotid sinus directly rather than the vagus) has shown more consistent results and has received regulatory approval in some markets for resistant hypertension.
Practical Implications
Vagal approaches are not a replacement for antihypertensive medication in people with established hypertension. The blood pressure reductions achieved through breathing exercises and HRV biofeedback are modest (3-9 mmHg systolic) compared to first-line medications (10-20 mmHg systolic for most drug classes). However, they are meaningful as adjunctive therapy — added to medication, they may allow lower doses, improve blood pressure control, and reduce cardiovascular risk through direct improvements in vagal tone and baroreflex function.
For people with borderline or stage 1 hypertension (systolic 120-139 mmHg) who are not yet on medication, vagal training through daily slow breathing practice combined with regular exercise and dietary sodium reduction may be sufficient to maintain blood pressure in the normal range and delay or avoid the need for medication.
Blood pressure is one of many cardiovascular parameters your vagus nerve helps regulate. My Vagus Nerve & Me covers the full cardiovascular role of the vagus nerve and explains how to strengthen your vagal brake through evidence-based training. Get My Vagus Nerve & Me eBook and take an autonomic approach to cardiovascular health.
